Scott Ferguson’s GeneDx Holdings Warrant WGSWW Stock Holding History

Scott Ferguson’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,155,000	Closed	-$1.13M	–	23
2021 Q4	$1.13M	Hold	1,155,000	–	–	0.03%	19
2021 Q3	$2.45M	Hold	1,155,000	–	–	0.06%	21
2021 Q2	$5.31M	Hold	1,155,000	–	–	0.14%	20
2021 Q1	$5.98M	Buy	+1,155,000	New	+$6.42M	0.16%	20

Other funds holding WGSWW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Scott Ferguson's WGSWW Position: Q1 2022 in Review

Scott Ferguson sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 1,155,000 shares — an estimated $1.13M sold.

Scott Ferguson first reported a position in WGSWW in Q1 2021 and held it in 4 quarters. The position peaked at $5.98M in Q1 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

Scott Ferguson reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
Scott Ferguson sold 1,155,000 GeneDx Holdings Warrant shares in Q1 2022, an estimated $1.13M.
Scott Ferguson first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 4 quarters.
Scott Ferguson's GeneDx Holdings Warrant position peaked at $5.98M in Q1 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on Sachem Head Capital Management's 13F filing for Q1 2022, filed 13 May 2022.